Technical Data
Cadherin E (Cadherin 1, E-Cadherin, L-CAM, Epithelial Cell Adhesion Molecule, Uvomorulin, CDH1)
Cadherins are a multifunctional family of Ca2+-dependent, transmembrane glycoproteins which promote and maintain cell adhesion in virtually all multicellular organisms. The cadherin superfamily comprises over forty proteins which are, on average, 50-60% homologous. Cadherin expression is required for the assembly of cells into solid tissues and importantly, cadherins are expressed in a tissue specific fashion. Homotypic cellular interactions are promoted by homophillic interactions between the extracellular regions of like cadherin molecules on neighboring cells. Recent crystal structure analysis of an extracellular cadherin domain suggests that individual cadherin molecules cooperate to form a linear cell adhesion zipper. In adherens junctions, cadherins are anchored to the actin cytoskeleton by interaction with the small cytoplasmic proteins b-catenin and -catenin which both bind to the actin binding protein a-catenin.bThe interaction of b- catenin with the cytoplasmic tail of cadherins and other cytoplasmic proteins, including Tcf-family transcription factors and the tumor suppressor protein APC, is thought to be mediated through a region of the b-catenin molecule containing multiple repeats of the 42 amino acid armadillo sequence motif. In addition to playing important roles in differentiation and tissue morphogenesis, cadherins also appear to play a significant role in modulating tumor invasion and metastasis. The expression of E-cadherin correlates inversely with the motile and invasive behavior of tumor cells.
Suitable for use in Immunofluorescence, Flow Cytometry, Immunohistochemistry, Immunoblotting, Western Blot and Immunoprecipitation. Other applications not tested.

Recommended Dilutions:
Immunohistochemistry (Paraffin, frozen):10ug/ml for paraffin sections
Western Blot: 1-10ug/ml
Immunoblot: 1-2ug/ml
Optimal dilutions to be determined by the researcher.

Storage and Stability:
Lyophilized powder may be stored at -20C. Stable for 12 months at -20C. Reconstitute with sterile ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20C. Reconstituted product is stable for 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
MabIgG2a3G44Highly Purified
100ug-20CBlue IceMouseRat
~2mg/ml (after reconstitution)
Mouse liver E-cadherin fragment.
Puri ed by ammonium sulfate precipitation and anion exchange chromatography.
Supplied as a lyophilized powder from PBS, 1% BSA. Reconstitute with 50ul sterile ddH20. Recommended Diluent: PBS, 0.09% sodium azide, 1% BSA.
Recognizes mouse Cadherin E. Moderate crossreactivity and limited af nity with human E-cadherin.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Ozawa, M., et al., EMBO J. 8: 1711-1717 (1989). 2. Takeichi, M., Science 251: 1451-1455 (1991). 3. Tang, A., et al., Nature 361: 82-85 (1993). 4. Tsarfaty, I., Science 263: 98-101 (1994). 5. Horiguchi, Y., et al., J. Histochem. Cytochem. 42: 1333-1340 (1994). 6. Aberle, H., et al., (1994) J. Cell Sci. 107: 3655-3663. 7. Roh, J-Y. and Stanley, J.R., J. Cell Biol. 128: 939-947 (1995). 8. Fannon, A., et al., J Cell Biol 129: 189-202 (1995). 9. Shapiro, L., et al., (1995) Nature 374: 327-337. 10. Babich, M. and Foti, L., Life Sciences 54: 201-208 (1995). 11. Shibamoto, S., et al., J. Cell Biol. 128: 949-957 (1995). 12. Mbalaviele, G., et al., Cancer Res 56: 4063-4070 (1996). 13. Marrs, J.A., and Nelson, W.J., Intl. Rev. of Cytology 165: 159-205 (1996). 14. Jiang, W.G., British Journal of Surgery 83: 437-446 (1996). 15. Huber, A.H., et al., Cell 90: 871-882 (1997). 16. Schofield, K., et al., Cancer 81: 293-298 (1997). 17. Soler, A.P., et al., Am. J. Pathol. 151: 471-478 (1997). 18. Dunn, R.J., et al., J. Histochem. Cytochem. 45: 129-141 (1997). 19. Kuroda, et al., Science 181: 932-835 (1998). 20. Gallicano, G.I., et al., J. Cell Biol. 143: 2009-2022 (1998). 21. Perl, A., et al., Nature Medicine 5: 286-291 (1999).